Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.

about

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.

Item

http://www.wikidata.org/entity/Q55230733

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@en

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@nl

type

Item

label

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@en

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@nl

prefLabel

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@en

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@nl

P1476

Mechanisms responsible for inc ...... diomyopathy and heart failure.

@en

P2093

Andrew J Taylor

http://www.w3.org/2001/XMLSchema#string

Andris H Ellims

http://www.w3.org/2001/XMLSchema#string

Anthony M Dart

http://www.w3.org/2001/XMLSchema#string

David M Kaye

http://www.w3.org/2001/XMLSchema#string

Donna Vizi

http://www.w3.org/2001/XMLSchema#string

Helen Kiriazis

http://www.w3.org/2001/XMLSchema#string

Julie R McMullen

http://www.w3.org/2001/XMLSchema#string

Junichi Sadoshima

http://www.w3.org/2001/XMLSchema#string

Lu Fang

http://www.w3.org/2001/XMLSchema#string

My-Nhan Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

How galectin-3 changes acute heart failure decision making in the emergency department

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.

Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.

Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.

Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis.

Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).

P304

8213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-26115-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29844319

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

5973942

http://www.w3.org/2001/XMLSchema#string